Raymond James Financial
KRRO icon

Raymond James Financial’s Korro Bio KRRO Stock Holding History

Raymond James Financial’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$485K Buy
42,838
+19,807
+86% +$218K ﹤0.01% 4360
2025
Q4 		$184K Sell
23,031
-125,940
-85% -$2.94M ﹤0.01% 4814
2025
Q3 		$7.13M Buy
148,971
+65,579
+79% +$1.46M ﹤0.01% 2195
2025
Q2 		$1.04M Buy
83,392
+65,170
+358% +$938K ﹤0.01% 3558
2025
Q1 		$317K Buy
18,222
+7,875
+76% +$234K ﹤0.01% 4193
2024
Q4 		$394K Buy
+10,347
New +$532K ﹤0.01% 4040

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Raymond James Financial's KRRO Position: Q1 2026 in Review

Raymond James Financial increased its Korro Bio (KRRO) stake by 86% in Q1 2026, buying an estimated $218K and bringing the position to 42,838 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #4360.

Raymond James Financial first reported a position in KRRO in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.13M in Q3 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Raymond James Financial held 42,838 shares of Korro Bio worth $485K as of Q1 2026.
  • Raymond James Financial bought 19,807 Korro Bio shares in Q1 2026, an estimated $218K.
  • Korro Bio made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4360 holding.
  • Raymond James Financial first reported a position in Korro Bio in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Korro Bio position peaked at $7.13M in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.